NRF2-COX2-PGE2 axis drives immune cold tumors and predicts resistance to combination immunotherapy in hepatocellular carcinoma.

Journal:

Hepatology

Published:

2026-01-16

DOI:

10.1097/hep.0000000000001677

Affiliations:

14

Authors:

26

Go to article

Institutions	Authors	Share
The University of Osaka (UOsaka), Japan	11.000000 11.000000	0.42
Iizuka Hospital, Japan	2.000000	0.08
Osaka International Cancer Institute, Japan	2.000000	0.08
Osaka Rosai Hospital, Japan	2.000000	0.08
National Institute of Global Health and Medicine, Japan	1.500000	0.06
Icahn School of Medicine at Mount Sinai (ISMMS), MSHS, United States of America (USA)	1.000000	0.04
Hokkaido University, Japan	1.000000	0.04
Osaka Keisatsu Hospital, Japan	1.000000	0.04
National Hospital Organization Osaka National Hospital, Japan	1.000000	0.04
JCHO Osaka Hospital, Japan	1.000000	0.04
Kyoto University, Japan	1.000000	0.04
Kansai Rosai Hospital, Japan	1.000000	0.04
The University of Tokyo (UTokyo), Japan	0.500000	0.02

Interested in Oncology and Carcinogenesis?